Press Releases

ROCHESTER, N.Y., Dec. 12, 2019 /PRNewswire/ -- Health Care Originals (HCO), a leading digital health tech and wearable devices company that provides the only patch-type ambulatory cough monitor in the world, is pleased to announce a collaboration with Dr. Laurie Slovarp, of the University of Montana, who is pione

SAN CARLOS, Calif. and WASHINGTON, Dec. 12, 2019 /PRNewswire/ -- The Lung Cancer Registry has launched new surveys to do an even better job of capturing important moments in a patient's lung cancer journey. These new surveys include questions about how symptoms and side effect impact quality of life—now and over time.

SILVER SPRING, Md., Dec. 12, 2019 /PRNewswire/ -- Today, Bcureful and the Tuberous Sclerosis Alliance (TS Alliance) announced plans to formally combine efforts, specifically by establishing the Bcureful Travel Fund at the TS Alliance. 

MADISON, Wis., Dec. 12, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced new outcomes data from two large population-based studies1,2 presented at the

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- In 2019, Sweden and India celebrate 10 years of collaboration under a Memorandum of Understanding (MoU) on Health. It also marks 10 years of our local presence as HemoCue India. Globally, as well as locally, we share our commitment in s

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- In the latest version of Ortoma Treatment Solution, OTS 4, Ortoma has introduced support of Artificial Intelligence. The system drastically reduces the time needed for pre-operatively planning of a hip implant in 3D, which has created a big interest for the company's unique solution. Performance has been a focus

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB): On Monday the topline results were presented from the first study in the Phase 3 program for MOB-015, where the primary endpoint and the two key secondary endpoints were met. Since the results are somewhat contradictory and the company has received many questions, we want to clarify the vario

SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that new data from the global phase III FeDeriCa study conducted by Genentech, a member of the Roche Group, will be presented today at the 2019 San Antonio Breast Cancer Symposium (SABCS). The FeDeriCa study investigated a fixed-dose combination (FDC) of pertuzumab

SUZHOU, China, Dec. 12, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received the approval from the Human Research Ethics Committee (HREC) in Australia, and the acknowledgement from Australia's Therapeutic Goods Admin

OSLO, Norway, Dec. 12, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) reports an update on its LYMRIT 37-05 Phase 1 trial of Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) who are not eligible for autologous stem cell transplantation (SCT). DLBCL is an aggressive form of non-Hodgkin's lymphoma (NHL) and accounts for